Publication | Open Access

Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma

Hematological MalignancyOncologyHematologyMyeloid NeoplasiaLiposomal DoxorubicinMultiple MyelomaFirst-line TreatmentPharmacotherapyMedicineRadiation OncologyHealth Sciences